Description
Trifluridine and Tipiracil, marketed under the brand name LONSURF, It is an prescription medication that has been approved trifluridine and tipiracil (LONSURF, Taiho Oncology, Inc.), On August 2, 2023
What is LONSURF (Trifluridine and tipiracil) ?
LONSURF (trifluridine and tipiracil) tablets for intravenous infusion. Initial U.S. Approval: 2004.
LONSURF is indicated for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF biological therapy, and if RAS wild-type, an anti-EGFR therapy
Trifluridine/tipiracil, sold under the brand name Lonsurf, is a fixed-dose combination medication that is used as a third- or fourth-line treatment of metastatic colorectal cancer or gastric cancer, after chemotherapy and targeted therapeutics have failed. It is a combination of two active pharmaceutical ingredients: trifluridine, a nucleoside analog, and tipiracil, a thymidine phosphorylase inhibitor. Tipiracil prevents rapid metabolism of trifluridine, increasing the bioavailability of trifluridine.
How to order approved “LONSURF (Trifluridine and tipiracil) for Tablets” Medicine?
LONSURF (Trifluridine and Tipiracil) Tablets is a prescription medicine, it can be accessed through the Named Patient Program (NPP) for treatment in the following city of India – Bengaluru, Delhi, Chennai, Hyderabad, Mumbai, Pune, Kolkata, Ahmedabad, Gurgaon. To inquire about the cost price of purchasing LONSURF and arranging delivery to your location, please get in touch with Mr. Rakesh at +91 9910645395 or send an enquiry to info@cancermedicinesnetwork. We assure you of the quality of the product and guarantee delivery in accordance with your specific requirements.
